Regulatory Insights & Submission Playbooks

Expert insights and submission playbooks for regulatory operations, publishing, and quality teams working across pharma, biotech, and medical devices.

ectd module 5 clinicalectd module 5

eCTD Module 5: Clinical Study Reports and Data Organization Guide

Guide

clinical study reports ectd

module 5 clinical data organization

eCTD Module 5 guide for clinical study reports and data organization. ICH E3 format, study categorization, tabular listings, and cross-referencing to Module 2.

Assyro Team20 min read

Mar 16, 2026Updated Apr 8, 2026

ectd module 4 nonclinicalectd module 4

eCTD Module 4: Nonclinical Study Reports and Data Organization

Guide

nonclinical study reports ectd

module 4 toxicology pharmacology

eCTD Module 4 guide for nonclinical study reports. Pharmacology, pharmacokinetics, toxicology organization per ICH M4S and CTD structure requirements.

Assyro Team16 min read

Mar 15, 2026Updated Apr 8, 2026

ectd module 3 quality cmcectd module 3

eCTD Module 3: Quality (CMC) Documentation Complete Guide

Guide

cmc documentation ectd

module 3 drug substance drug product

eCTD Module 3 guide for quality CMC documentation. Drug substance, drug product, manufacturing, specifications, stability data per ICH M4Q and CTD structure.

Assyro Team16 min read

Mar 14, 2026Updated Apr 8, 2026

ectd module 2 summariesectd module 2

eCTD Module 2: Quality Overall Summary and Clinical Overview Guide

Guide

quality overall summary

clinical overview ectd

eCTD Module 2 guide covering sections 2.1-2.7. Quality Overall Summary, Nonclinical and Clinical Overviews, Tabulated Summaries per ICH M4 guidance.

Assyro Team19 min read

Mar 13, 2026Updated Apr 8, 2026

fda user fee programspdufa user fees

FDA User Fee Programs: PDUFA, GDUFA, BSUFA, and MDUFA Explained

Guide

gdufa fda

fda review fees

FDA user fee programs explained: PDUFA, GDUFA, BSUFA, and MDUFA history, fee types, performance goals, and reauthorization cycles for drug and device review.

Assyro Team15 min read

Mar 12, 2026Updated Apr 8, 2026

ectd module 1 requirementsectd module 1

eCTD Module 1: Regional Administrative Information and Requirements Guide

Guide

ectd administrative information

module 1 regional requirements

eCTD Module 1 guide covering regional administrative requirements for FDA, EMA, and Health Canada. Forms, cover letters, patent info, labeling, and more.

Assyro Team17 min read

Mar 12, 2026Updated Apr 8, 2026

fda approval process step by stepfda drug approval process

FDA Drug Approval Process: Complete Step-by-Step Guide From Discovery to Market

Guide

how does fda approve drugs

fda approval steps

FDA drug approval process step by step from preclinical testing through NDA/BLA review and post-market surveillance. Every stage, requirement, and milestone.

Assyro Team20 min read

Mar 11, 2026Updated Apr 8, 2026

fda standard vs priority reviewpriority review fda

FDA Standard Review vs Priority Review: Criteria, Timelines, and Differences

Guide

fda review timeline

priority review designation

FDA standard review vs priority review comparison: eligibility criteria, 10-month vs 6-month timelines, priority review vouchers, and PDUFA VII commitments.

Assyro Team15 min read

Mar 10, 2026Updated Apr 8, 2026

health canada vs fdahealth canada fda comparison

Health Canada vs FDA: Drug Approval Process Comparison

Comparison

canadian drug approval vs fda

nds vs nda

Health Canada vs FDA comparison covering drug approval processes, submission types, review timelines, Module 1 differences, labeling formats, and expedited.

Assyro Team18 min read

Mar 9, 2026Updated Apr 8, 2026

...